ARTHROCARE CORP
ARTC
ARTC was delisted on the 29th of May, 2014.
0 hedge funds and large institutions have $0 invested in ARTHROCARE CORP in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 117 closing their positions.
100% less funds holding
Funds holding: 117 → 0 (-117)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $1.61B → $0 (-$1.61B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 117
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$310M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$152M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$118M |
| 4 |
PC
Paulson & Co
New York
|
-$96.4M |
| 5 |
WIC
Water Island Capital
New York
|
-$91.2M |
ARTC Hedge Fund Activity: Q2 2014 in Review
0 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q2 2014, worth a combined $0 — down 100% from $1.61B a quarter earlier.
Sellers outnumbered buyers: 117 funds closed out of ARTC and 0 opened new positions — a net loss of 117 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was JP Morgan Chase, exiting entirely with an estimated $310M sold.
- 0 institutional investors held ARTHROCARE CORP (ARTC) as of Q2 2014, down from 117 in Q1 2014.
- Funds reported $0 of ARTHROCARE CORP stock for Q2 2014, down 100% quarter-over-quarter.
- 0 funds opened new ARTHROCARE CORP positions in Q2 2014 and 117 closed out, a net change of -117 holders.
- The largest ARTHROCARE CORP seller in Q2 2014 was JP Morgan Chase, an estimated $310M sold.
Based on aggregated 13F filings for Q2 2014.